Hi guys, ive been tracking LMND since february as i noticed we were interacting with major resistance trend line that formed since its top in 2021. Just to mention its extremely hard to predict what goes on in the markets, and i was somewhat wrong in my short term prediction in my previous charts. As we made a lower low ($10.37). BUT im still long this company and...
Hi guys. Lemonade, Inc. has caught my attention with its recent price action. This will be strictly TA based, as thats what im into.
Jumping right in. This analysis is on the Daily Timeframe. Ill probably have more charts up looking at larger timeframes and updating when i see fit for each timeframe.
So on the chart we have:
1. A green box - which is in my...
Lemonade
Short Term
We look to Sell at 22.81 (stop at 25.17)
Preferred trade is to sell into rallies. Trades with a bearish descending triangle formation. Previous resistance located at 23.00. The medium term bias remains bullish. There is scope for mild upward pressure at the open but we look for selling interest to resist gains.
Our profit targets will...
LMND is oversold - Retest of 50 day EMA - 21 week EMA is expected. This will correspond to the wave 4 target, which also happens to be the top of the channel trendline. We are in a zig-zag corrective structure which means a fifth wave to the downside is expected post retest. We are, nevertheless, in a downtrend channel!
LMND Daily TF
Analysis
After a steep correction to 58 from ATH in January at 180s... Lmnd is looking primed for a downtrend breakout. The AI driven Insurance company has grown from homeowners & renters insurance to pet insurance and now planning to get into the auto mobile insurance which gives a good outlook for growth in the coming years. The stock price...
I'm really excited about the Lemonade company and believe they could provide a real upset in the outdated insurance industry.
The recent price drop seems to have caught people out - but to me seems like a normal retest, their rise has been fairly quick after all and this movement seems healthy for the stock. The Q4 earnings report had nothing sinister or overly...
